Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems.
Looking for a particular Ischemix employee's phone or email?
The Ischemix annual revenue was $1 million in 2026.
David Dewahl is the President and Chief Executive Officer of Ischemix.
3 people are employed at Ischemix.
Ischemix is based in Maynard, Massachusetts.
The NAICS codes for Ischemix are [32, 32541, 325, 3254].
The SIC codes for Ischemix are [28, 283].